Homa Dadras, MD

US-IMG | Postdoctoral Researcher at @KECKSchool_USC | Hematology and Oncology department

[Homa Dadras, MD @HomaDadras]

• Hold the vision, Trust the process •
Finally got a picture of myself in front of the NRT building! Grateful to work here everyday!
@uscnorris
#WomeninMedicine #IMGjourney

[Oren Gottfried, MD @OGdukeneurosurg]

Rbc variants

[Homa Dadras, MD @HomaDadras]

Great talk by Dr. Roberto Mina on CAR-T vs. T-cell engagers in early RRMM! Really enjoyed the discussion on bispecific antibodies vs. CAR-T and how some RRMM patients may benefit from the Tec+dara combination as an alternative to CAR-T therapy.

@RobertoMinaMD #MultipleMyeloma

[Homa Dadras, MD @HomaDadras]

Great start to the weekend! Always inspiring to hear new perspectives and see the science moving forward at the Cedars-Sinai Lymphoma & Myeloma Summit 2026.

[Homa Dadras, MD @HomaDadras]

October is Breast Cancer Awareness Month.

Thinking of all the patients, survivors, families, and researchers working toward a world without breast cancer. 🩷

A little reminder to check your breasts and pay attention to any changes. Early detection matters.

[Homa Dadras, MD @HomaDadras]

It was a great experience attending #EHA2025 and even more meaningful to be awarded the travel grant.
Proud to be part of this incredible community and to learn from the forefront of hematology research.
@EHA_Hematology

[Homa Dadras, MD @HomaDadras]

Thrilled to present our research work at the #EHA2025 .A special thanks to my mentor @KellyLabUSC and the EHA community for this wonderful experience!
#AML @EHA_Hematology
@uscnorris

[Homa Dadras, MD @HomaDadras]

Selinexor, XPO inhibitor
#EHA2025

[Homa Dadras, MD @HomaDadras]

Treatment landscape in multiple myeloma today: realistic situation
#EHA2025

[Homa Dadras, MD @HomaDadras]

Treatment landscape in MM in the future.
Great talk by @mvmateos
#EHA2025

[Homa Dadras, MD @HomaDadras]

#EHA2025 moments!

[Homa Dadras, MD @HomaDadras]

Machine learning and AI help identify patterns, predict outcomes, and accelerate innovations in hematology.
Great talk by @jnkath at #EHA2025

[Homa Dadras, MD @HomaDadras]

Such a great session on the management of RRMM. Learned so much!
#EHA2025

[Homa Dadras, MD @HomaDadras]

So excited to attend EHA in Milan for the first time! Can’t wait to meet mentors, scientists, and everyone in the community! #EHA2025

[Keith Siau @drkeithsiau]

Steroids 😅

[European Hematology Association @EHA_Hematology]

#EHA2025 is an opportunity for hematology researchers from across the world to exchange novel data, learn, and grow. Register now: https://t.co/QdPnj8gVil

[Mark Lewis, MD, FASCO @marklewismd]

Mismatch repair proteins:

[Homa Dadras, MD @HomaDadras]

Incredible talk by @ProfGLongMIA on neoadjuvant immunotherapy for Melanoma patients.
The dedication and hard work behind these clinical trials are truly inspiring.
#AACRIO2025

[Homa Dadras, MD @HomaDadras]

Great talks on spatial organization of immune cells and treatment with immunotherapy! #AACRIO25

[Homa Dadras, MD @HomaDadras]

Excited for the #AACRIO25 !

[Negar Nekooei @nnekoooei]

🚨 Hot off the press! 🔥

Identifying trauma populations benefiting most from REBOA is crucial. Our study evaluates outcomes in penetrating abdominal vascular injuries.

I’m grateful for Dr. Demetriades’ guidance and support 🙏🏻

@LACUSCTrauma